| Literature DB >> 32202164 |
Longgang Jia1,2, Wenping Zhao1, Wei Wei1, Xiao Guo1, Wenjuan Wang1, Ying Wang1, Jingcheng Sang1, Fuping Lu1, Fufeng Liu1.
Abstract
Misfolding and accumulation of amyloidogenic proteins into various forms of aggregated intermediates and insoluble amyloid fibrils is associated with more than 50 human diseases. Large amounts of high-quality amyloid proteins are required for better probing of their aggregation and neurotoxicity. Due to their intrinsic hydrophobicity, it is a challenge to obtain amyloid proteins with high yield and purity, and they have attracted the attention of researchers from all over the world. The rapid development of bioengineering technology provides technical support for obtaining large amounts of recombinant amyloidogenic proteins. This review discusses the available expression and purification methods for three amyloid proteins including amyloid β-protein, tau, and α-synuclein in microbial expression systems, especially Escherichia coli, and discusses the advantages and disadvantages of these methods. Importantly, these protocols can also be referred to for the expression and purification of other hydrophobic proteins.Entities:
Keywords: E. coli expression system; Protein conformational disease; amyloid protein; heterogenous protein expression; purification
Year: 2020 PMID: 32202164 DOI: 10.1080/07388551.2020.1742646
Source DB: PubMed Journal: Crit Rev Biotechnol ISSN: 0738-8551 Impact factor: 8.429